Robert Fallon, MD, PhD
Zachary E. Klingler Professor of Pediatrics
705 Riley Hospital Drive, ROC 4340
Indianapolis, IN 46202
Pediatric Hematology Oncology
Areas of Interest
Pediatric Oncology, Hodgkins Disease and Lymphoma; Sickle Cell Disease; Clinical trials on new cancer drugs.
I have been Section Director of Pediatric Hematology-Oncology at Riley Hospital for Children since 2000. I serve as the Institutional Principal Investigator for the Childrens Oncology Group.
|1974||BS Yale University|
|1980||MD, PhD New York University|
Honors & Awards
- Basil O’Connor Research Award, March of Dimes 1989
- Lauri Strauss Leukemia Foundation Research Award 1991
Riley Outpatient Center
705 Riley Hospital Drive
Indianapolis, IN 46202
Research & Grants
Clinical trials through Childrens Oncology Group; Phase I, II, III trials of new cancer drugs and combinations
Childrens Oncology Group, Operations grant, Institutional PI at Indiana University (over 90 protocols)
Fallon RJ, Schwartz AL. Receptor-mediated endocytosis and targeted drug delivery. Hepatol 1985; 5:899-901.
Batanian JR, Huang Y, Fallon RJ. Deletion of 3’-CBFB gene in association with an inversion (16) (p13q22) and a Loss of the Y Chromosome in a 2 year old child with acute myelogenous leukemia – M4. Cancer Genet Cytogenet 2000; 121:216-219
Kumar M, Fallon RJ, Hill JS, Davis MM. Esthesioneuroblastoma in children. J. Ped. Hem Onc, 2002; 24:482-487.
Adams GB, Chabner KT, Foxall RB, Weibrecht KW, Rodrigues NP, Dombkowski D, Fallon R, Poznansky MC, Scadden DT. Heterologous cells cooperate to augment stem cell migration, homing, and engraftment. Blood, 2003; 101:45-51.
Hulbert ML, Scothorn DJ, Panepinto J, Scott JP, Buchanan GR, Shurney W, Sarniak I, Fallon R,et al. Exchange blood transfusion for first overt stroke is associated with a lower risk of subsequent stroke than simple transfusion: a retrospective cohort of 137 children with sickle cell anemia. J Pediat, 2006, 149: 710-712.
Fallon RJ, Olshan A, Saxman S. Male genital tract cancer. In Bleyer A, O’Leary M, Barr R, Ries LAG, eds: Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 years of age, including SEER Incidence and Survival: 1975-2000. National Cancer Institute, NIH Pub. No. 06-5767. Bethesda MD, 2006, p. 155-162.
Creary S, Heiny M, Croop J, Fallon R, Vik T, Lee ND, Hulbert M, Knoderer H, Kumar M, Sharathkumar A. Clinical course of post-thrombotic syndrome in children with history of venous thromboembolism (VTE). Blood Coagul Fibrinolysis, 2012, 23: 39-44.